Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Original Biomedicals CoROCO:6483 -1.87%32 Quick Ratio is 9.74 as of Dec. 2025, which is 8% below its 10-year median of 10.59. GuruFocus rates ROCO:6483 with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 999 Drug Manufacturers companies, Original Biomedicals Co ranks better than 94.59% on this metric.
Original Biomedicals Co has a quick ratio of 9.74. It generally indicates good short-term financial strength.
The historical rank and industry rank for Original Biomedicals Co's Quick Ratio or its related term are showing as below:
ROCO:6483'
s Quick Ratio Range Over the Past 10 Years
Min: 5.77 Med: 10.59 Max: 17.77
Current: 9.74
During the past 9 years, Original Biomedicals Co's highest Quick Ratio was 17.77. The lowest was 5.77. And the median was 10.59.
ROCO:6483's Quick Ratio is ranked better than 94.59% of 999
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs ROCO:6483: 9.74
Original Biomedicals Co (ROCO:6483) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Original Biomedicals Co Quick Ratio Related Terms
Original Biomedicals Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Original Biomedicals Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Original Biomedicals Co Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Original Biomedicals Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Original Biomedicals Co's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Original Biomedicals Co's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Original Biomedicals Co (ROCO:6483) has a Quick Ratio of 9.74 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Original Biomedicals Co and its competitors. This is near median its historical median of 10.59. Over the past decade, Original Biomedicals Co's Quick Ratio has ranged from 5.77 to 17.77. According to the industry distribution chart, Original Biomedicals Co ranks #54 out of 999 companies in the Drug Manufacturers industry, placing it in the top 5.4%.
Is Original Biomedicals Co's Quick Ratio too high?
Original Biomedicals Co's current Quick Ratio of 9.74 is near median its 10-year median of 10.59. Over the past 10 years, this metric has ranged from a low of 5.77 to a high of 17.77. The Drug Manufacturers industry median Quick Ratio is 1.45. Original Biomedicals Co's value of 9.74 is 571.7% above this industry median. Based on the distribution chart, Original Biomedicals Co ranks #54 out of 999 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Original Biomedicals Co has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Original Biomedicals Co's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Original Biomedicals Co ranks #54 out of 999 companies for Quick Ratio. This places Original Biomedicals Co in the top 5% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Original Biomedicals Co's value of 9.74 is 571.7% above this benchmark. Historically, Original Biomedicals Co's own Quick Ratio has ranged from 5.77 to 17.77 over the past decade. While the company's 10-year median is 10.59 vs. the industry median of 1.45, Original Biomedicals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 999 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Original Biomedicals Co's current Quick Ratio of 9.74 is 571.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Original Biomedicals Co and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Original Biomedicals Co's current Quick Ratio is 9.74, which is near median its own 10-year median of 10.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Original Biomedicals Co stock overvalued right now?
Original Biomedicals Co (ROCO:6483) has a current Quick Ratio of 9.74. The current Quick Ratio is 9.74, which is near median its 10-year median of 10.59 and 571.7% above the Drug Manufacturers industry median of 1.45. Original Biomedicals Co's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Original Biomedicals Co (ROCO:6483), the current Quick Ratio is 9.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Original Biomedicals Co Ltd is a biopharmaceutical company engaged in the research and development of drugs. The company focuses on developing new drug formulations, drug delivery systems, and repurposing existing pharmaceutical products.
32GF Score
Get the complete analysis for ROCO:6483
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6483 has been successfully added to your 
